일회용 주사기 시장 : 유형별, 바늘 유형별, 용량별, 재질별, 용도별, 최종 사용자별 시장 예측(2026-2032년)

The Disposable Syringes Market is projected to grow by USD 28.91 billion at a CAGR of 6.88% by 2032.

Disposable Syringes Market Executive Summary

Disposable syringes remain essential to safe medication delivery, vaccination, diagnostic sampling, emergency care, and chronic disease management. WHO has reported that roughly 16 billion injections are administered worldwide each year, making sterile, single-use injection devices a critical layer of infection prevention and patient safety.

Demand for disposable syringes is supported by immunization programs, diabetes care, biologics administration, hospital procedures, and public health preparedness. Healthcare buyers increasingly prioritize auto-disable syringes, safety-engineered needles, traceable sterilization records, ISO-aligned quality systems, and dependable supply continuity across regulated healthcare environments.

Safety, Sustainability, and Supply Chain Shifts

The disposable syringes landscape is shifting from commodity purchasing toward safety, compliance, and resilient sourcing. Needlestick injury prevention rules, hospital infection-control protocols, WHO injection safety guidance, and vaccine delivery standards continue to favor safety syringes, auto-disable syringes, and sterile single-use formats.

Manufacturers are also responding to resin cost volatility, ethylene oxide sterilization scrutiny, medical waste concerns, and demand for prefilled or ready-to-administer formats. Competitive advantage is moving toward suppliers that can combine scale, regulatory documentation, validated sterilization, strong lot traceability, and lower-risk global logistics.

AI's Cumulative Impact on Disposable Syringes

Artificial intelligence is increasingly cumulative across the disposable syringe value chain rather than limited to a single use case. AI-supported demand forecasting can combine immunization schedules, tender cycles, hospital utilization patterns, seasonal disease signals, and inventory data to reduce stockouts, expired stock, and avoidable production imbalances.

In manufacturing, machine vision and predictive maintenance help detect barrel, plunger, needle, hub, labeling, and packaging defects earlier. AI also strengthens supplier-risk monitoring, documentation review, sterilization batch analytics, and inventory allocation, but adoption must remain aligned with ISO 13485 quality systems, FDA quality expectations, EU MDR requirements, cybersecurity controls, and validated data governance.

Regional Demand Patterns and Market Access Signals

Asia-Pacific is a high-volume growth center because China and India combine large patient populations, expanding domestic medical device manufacturing, high immunization activity, and rising chronic disease care needs, while ASEAN markets benefit from hospital expansion, regional procurement programs, and improving healthcare access. North America remains a value-focused region where FDA oversight, OSHA needlestick prevention requirements, CDC immunization infrastructure, and centralized healthcare purchasing strengthen adoption of safety-engineered disposable syringes.

Europe is shaped by EU MDR compliance, mature hospital procurement, occupational safety requirements, and growing sustainability pressure around medical packaging and healthcare waste. Latin America depends heavily on public tenders and immunization procurement, with Brazil and Mexico serving as major demand anchors through national health systems and regulatory oversight. The Middle East, particularly the GCC, is investing in hospital capacity, specialized care, and reliable import channels, while Africa's demand is closely tied to vaccination access, donor-supported procurement, primary care expansion, and cold-chain-linked public health programs.

Trade-Bloc and Alliance Insights for Disposable Syringes

ASEAN demand is supported by healthcare access expansion, medical tourism hubs, immunization programs, and increasing regulatory cooperation, creating opportunities for cost-competitive sterile disposable syringe suppliers that can meet quality and documentation requirements. The GCC emphasizes centralized procurement, premium hospital infrastructure, and reliable import channels for safety syringes, specialty syringes, and products used in acute care and preventive health programs.

The European Union sets a high compliance benchmark through MDR, occupational safety rules, waste-management expectations, and safety-device adoption across mature health systems. BRICS countries combine large domestic demand with local manufacturing ambitions, especially in China, India, and Brazil, while Russia continues to support supply localization where feasible. G7 markets reward innovation, quality documentation, regulatory transparency, and supply resilience, while NATO members increasingly view essential medical consumables, including syringes, as part of civil preparedness, emergency response, and strategic stockpiling.

Country-Level Opportunities in Disposable Syringes

The United States leads in safety-engineered syringe adoption through FDA regulation, CDC immunization infrastructure, OSHA needlestick requirements, and established hospital purchasing systems, while Canada emphasizes Health Canada compliance, provincial procurement, and public vaccination programs. Mexico and Brazil provide scale through public health systems, with COFEPRIS and ANVISA shaping market access, product registration, and quality expectations for imported and locally supplied disposable syringes.

In Europe, the United Kingdom, Germany, France, Italy, and Spain prioritize MDR-aligned supply, hospital safety, traceability, and sustainability-oriented procurement, while Russia continues to support import substitution and domestic production where feasible. China and India are major demand and production hubs driven by population scale, immunization demand, and expanding healthcare access; Japan and South Korea emphasize high-quality regulated devices, manufacturing precision, and safety standards; and Australia relies on TGA compliance, national immunization programs, and dependable healthcare distribution across urban and remote settings.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize safety-engineered and auto-disable syringe portfolios for vaccination, acute care, public health campaigns, and high-volume government procurement. Suppliers that document sterility assurance, extractables and leachables controls, biocompatibility, material consistency, labeling accuracy, and lot traceability are better positioned with hospitals, ministries of health, and regulated procurement bodies.

Executives should diversify resin, needle, plunger, and packaging suppliers across regions; use AI for demand sensing, quality inspection, and defect detection; and build evidence for lower-waste packaging without compromising sterility. Partnerships with local distributors, public health agencies, vaccination programs, and healthcare logistics providers can improve tender access, strengthen last-mile delivery, and reduce disruption risk.

Evidence-Based Research Methodology

This executive summary is grounded in secondary research from public health agencies, regulatory authorities, trade data, procurement frameworks, and standards bodies, including WHO, UNICEF, FDA, CDC, OSHA, Health Canada, European Commission MDR resources, national regulators, and recognized quality-management standards such as ISO 13485.

Findings were synthesized through triangulation across demand drivers, policy signals, manufacturing constraints, sterilization requirements, healthcare infrastructure, and regional procurement practices. The methodology emphasizes verified public evidence, regulatory consistency, and market-relevant interpretation rather than unsupported estimates, market sizing, share calculations, or speculative forecasts.

Conclusion: Building Safer, Scalable Injection Access

The disposable syringes market is evolving into a safety-led, compliance-intensive, and supply-resilience-driven industry. Sustained need from vaccination, chronic disease therapy, hospital care, diagnostics, emergency preparedness, and infection prevention will keep sterile single-use syringes central to global healthcare delivery.

Organizations that combine regulatory rigor, scalable manufacturing, validated sterilization, AI-enabled operations, and region-specific procurement strategies will be best positioned to support safer injections, maintain continuity of supply, and strengthen public health systems.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Disposable Syringes Market, by Type

• 7.1. Conventional Syringes
  • 7.1.1. 2-Part Syringes
  • 7.1.2. 3-Part Syringes
  • 7.1.3. Hypodermic Syringes
  • 7.1.4. Insulin Syringes
  • 7.1.5. Luer Lock Syringes
  • 7.1.6. Precision Syringes
• 7.2. Safety Syringes
  • 7.2.1. Non-Retractable Safety Syringes
  • 7.2.2. Retractable Safety Syringes

8. Disposable Syringes Market, by Needle Type

• 8.1. Blunt Tip Needle
• 8.2. Fixed Needle
• 8.3. Hypodermic Needle
• 8.4. Micro-needle
• 8.5. Removable Needle

9. Disposable Syringes Market, by Capacity

• 9.1. 1 mL-20 mL
• 9.2. <1 mL
• 9.3. >20 mL

10. Disposable Syringes Market, by Material

• 10.1. Biodegradable/Compostable Materials
• 10.2. Glass Syringes
• 10.3. Plastic Syringes
  • 10.3.1. Polycarbonate
  • 10.3.2. Polyethylene
  • 10.3.3. Polypropylene

11. Disposable Syringes Market, by Application

• 11.1. Cosmetics
• 11.2. Diagnostic
• 11.3. Therapeutic
  • 11.3.1. Drug Delivery
  • 11.3.2. Insulin Delivery
• 11.4. Vaccination
  • 11.4.1. Adult Vaccination
  • 11.4.2. Childhood Vaccination

12. Disposable Syringes Market, by End User

• 12.1. Ambulatory Surgical Centers
• 12.2. Diagnostic Laboratories
• 12.3. Home Healthcare
• 12.4. Hospitals & Clinics
• 12.5. Military & Field Medical Units
• 12.6. Veterinary Clinics

13. Disposable Syringes Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Disposable Syringes Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Disposable Syringes Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. AdvaCare Pharma
• 17.2. B. Braun SE
• 17.3. Baxter International, Inc.
• 17.4. Becton, Dickinson and Company
• 17.5. Cole-Parmer Instrument Company, LLC
• 17.6. Fresenius Kabi AG
• 17.7. GPE Group
• 17.8. Henke Sass Wolf GmbH
• 17.9. Hindustan Syringes & Medical Devices Ltd.
• 17.10. Hu-Friedy Mfg Co, LLC by Cantel Medical Corporation
• 17.11. ICU Medical, Inc.
• 17.12. ISCON SURGICALS LTD.
• 17.13. Jiangsu Shenli Medical Production Co., Ltd.
• 17.14. KD Medical GmbH Hospital Products
• 17.15. Nipro Corporation
• 17.16. Novo Nordisk A/S
• 17.17. Retractable Technologies, Inc.
• 17.18. Shree Umiya Surgical Pvt. Ltd.
• 17.19. Taizhou Sanxin Medical Technology Co., Ltd.
• 17.20. Terumo Corporation
• 17.21. Thermo Fisher Scientific Inc.
• 17.22. UltiMed, Inc.
• 17.23. Vita Needle Company
• 17.24. Weigao Meidcal international Co., Ltd
• 17.25. Yangzhou Medline Industry Co., Ltd.